The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Treatment
Clinical implementation of AI-based screening for risk for opioid use disorder in hospitalized adults
The article reports on an NIH-supported clinical trial showing that an artificial intelligence (AI)–based screening tool for opioid use disorder (OUD) can improve hospital outcomes without reducing quality of care. Embedded in the...
إدارة خدمات علاج اضطرابات استخدام المخدرات وفقًا للمعايير الدولية الأساسية للجودة
يهدف دليل إدارة خدمات علاج اضطرابات استخدام المخدرات وفقًا للمعايير الدولية الأساسية للجودة إلى مساعدة القادة والمديرين على ترجمة المعرفة الحالية وأفضل الممارسات الأخلاقية والفعّالة في مجال العلاج إلى تطبيق عملي. كما يساعد المديرين على...
Child and youth mental health in the WHO European Region: Status and actions to strengthen quality of care
For the first time WHO Regional Office for Europe brings together all of data available at the Regional level on child and youth mental health. One in seven children and adolescents aged 0–19 years old lives with a mental health condition...
Care without conditions — housing-first and employment-first approaches
Background: Across Europe, people who use drugs face persistent barriers to housing, decent work, healthcare and safety. All too often, ‘reintegration’ tends to be tied largely to abstinence, at the risk of excluding those who are not ready, or do not wish, to stop using psychoactive substances.
Day 1, 14:00 - 15:30, Plenary 3: Establishing Global-Regional Collaboration in Prevention, Treatment and Recovery Programs
Panel Presented at Indonesia 2025 on the 17th of September 2025 Moderator: Goodman Sibeko Presentations: Ma Veronica Felipe: International Consortium of Universities for Drug Demand Reduction Joanna Travis-Roberts: Global Opportunities for...
Mental Health Policy in the Management of Drug Abuse Disorders
The issue of drug (NAPZA) abuse at the global, regional, and national levels remains a serious public health issue, with widespread impacts on social, economic, and security domains. Based on the 2023 National Survey on Drug Abuse conducted by BNN, BRIN, and BPS, the prevalence rate of drug abuse in Indonesia among individuals aged 15–64 years was1.73%, equivalent to approximately 3.33 million people. Furthermore, the prevalence rate of drug use was 2.20%, or approximately 4.24 million people.
Day 1, 10:30 - 12:00, Plenary 1: A Landscape of Addiction Problem – Comprehensive Approach and Treatment
Panel Presented at Indonesia 2025 on the 17th of September 2025 Moderator: Vivi Syarif Presentations: Erik Van der Veen: From Evidence to Action: Building Partnerships to Strengthen the Drug Demand Reduction Strategy Bina Ampera Bukit...
Integrated Care for Syndemics: Bringing SUD, HIV & HCV Treatment Together
ISSUP Global presents a webinar on Integrated Care for Syndemics: Bringing SUD, HIV & HCV Treatment Together with Dr Sarah Kattakuzhy
Integrated Care for Syndemics: Bringing SUD, HIV & HCV Treatment Together
ISSUP Global, cordially invites you to an upcoming webinar on Integrated Care for Syndemics: Bringing SUD, HIV & HCV Treatment Together.
International Nurses Society on Addiction (IntNSA) Annual Education Conference 2026
Save the Date for Our 48th Annual Education Conference!
Monday, April 13 - Friday, April 17, 2026 I Hyatt at Olive 8 I Seattle, WA
Call for Abstracts